Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-06

Clinical Trial Update: North American Prodromal Synucleinopathy Consortium

View source ↗

Summary

This update covers the North American Prodromal Synucleinopathy Consortium trial led by Washington University School of Medicine. Enrollment is by invitation fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: REM Sleep Behavior Disorder, Parkinson Disease | Status: ENROLLING_BY_INVITATION